Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma.
about
Systemic delivery of microRNA-101 potently inhibits hepatocellular carcinoma in vivo by repressing multiple targetsPrognostic significance of cyclooxygenase-2 expression in patients with hepatocellular carcinoma: a meta-analysisBiology of hepatocellular carcinomaSilymarin downregulates COX-2 expression and attenuates hyperlipidemia during NDEA-induced rat hepatocellular carcinomaAnticancer and cytotoxic properties of the latex of Calotropis procera in a transgenic mouse model of hepatocellular carcinoma.Overexpression of cyclooxygenase-2 in noncancerous liver tissue increases the postoperative recurrence of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis.Role of HCV Core gene of genotype 1a and 3a and host gene Cox-2 in HCV-induced pathogenesis.Hepatitis C virus to hepatocellular carcinoma.A New Ligustrazine Derivative-Selective Cytotoxicity by Suppression of NF-κB/p65 and COX-2 Expression on Human Hepatoma Cells. Part 3Clinical implications of angiogenesis in cancers.Celecoxib suppresses autophagy and enhances cytotoxicity of imatinib in imatinib-resistant chronic myeloid leukemia cellsCyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma.The effects of a cyclooxygenase-2 (COX-2) expression and inhibition on human uveal melanoma cell proliferation and macrophage nitric oxide production.Inflammatory cell infiltration of tumors: Jekyll or Hyde.Vascular changes in hepatocellular carcinoma.Inflammation and cancer: how friendly is the relationship for cancer patients?HCV and oxidative stress in the liver.Efficacy and vitreous levels of topical NSAIDs.Inhibitory effect of presenilin inhibitor LY411575 on maturation of hepatitis C virus core protein, production of the viral particle and expression of host proteins involved in pathogenicity.Role of Modulator of Inflammation Cyclooxygenase-2 in Gammaherpesvirus Mediated Tumorigenesis.Mechanisms involved in PGE2-induced transactivation of the epidermal growth factor receptor in MH1C1 hepatocarcinoma cells.Dual action of a selective cyclooxygenase-2 inhibitor on vascular endothelial growth factor expression in human hepatocellular carcinoma cells: novel involvement of discoidin domain receptor 2.Amfenac increases the radiosensitivity of uveal melanoma cell lines.Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice.Ex vivo analysis of antineoplastic agents in precision-cut tissue slices of human origin: effects of cyclooxygenase-2 inhibition in hepatocellular carcinoma.VEGF in hepatocellular carcinoma and surrounding cirrhotic liver tissues.Quantitative analysis using ELISA of vascular endothelial growth factor and basic fibroblast growth factor in human colorectal cancer, liver metastasis of colorectal cancer and hepatocellular carcinoma.Clinical significance of Cox-2, Survivin and Bcl-2 expression in hepatocellular carcinoma (HCC).The Impact of Dietary Polyphenols on COX-2 Expression in Colorectal Cancer.Inhibitory effect of phytoglycoprotein (24 kDa) on hepatocarcinogenesis in N-nitrosodiethylamine-treated ICR mice.Primary Corneal Squamous Cell Carcinoma in a Dog: Clinical and Histopathological Evaluation
P2860
Q27311589-F7C954E2-AEAD-42CF-862E-10514ECDC71BQ28067391-E6ED800F-2243-4AAA-A4AF-14FE86EBA631Q28266656-18330BF5-E918-4608-BAB4-845E654798D5Q28583022-B32B3830-A785-4D3C-AF60-6DC77EC520C0Q33868476-AA3947A0-69D4-44B7-A625-7CFBB391EB5EQ34053320-BAF291F9-6D66-40EB-A461-A29E3FA76F65Q34832969-82FE8D6E-DC13-488B-9552-759FC771D957Q35800315-BB40B7FC-7D23-45F2-9181-F5F80E526580Q35902645-FCD81EFD-70AC-4934-A71D-DD237FE35114Q36012979-80C073A6-4E19-41B0-976E-383EE2566406Q36137461-18A6EE69-C8F0-4391-A0D4-B5F385CE0C77Q36306698-4CADE0C9-B990-478D-9903-70B5A5305A78Q36419349-C51A2E8D-3CD1-43F5-BEEA-E813712A0C00Q36918692-4373FB38-A6B6-44B7-8FC9-F3079C4E3C2FQ37165456-0A3F05AD-03AA-4CC9-9B3E-97BADAF4C32FQ37316105-FB811557-41EB-4366-B376-064BFF246C17Q38077447-A8D4C216-28D2-4AD2-97AC-A54D18E6B529Q38546915-3FD66E6B-5BD4-4FAB-B389-3C963B3C30BFQ38735011-40FB4B4B-A52B-403C-B207-120BAC476CDBQ39236102-6EC3491D-A619-4130-9653-AFC125CC9586Q39281043-0F70A616-39C3-40EB-8211-FC40B4B5B3BEQ39456277-08906661-FEFB-4769-B985-2188877DA9BBQ40042284-AD4277A2-6E99-4457-9763-00724FA506A2Q41245125-7A4411F3-E550-43B6-99AD-49AD4CF7C006Q42496570-4AD88605-5E00-4A61-8A4D-EB896883D937Q42704647-AFCAC025-0272-484A-9DAF-4A597EE0E931Q42725937-2D4223FD-6CC9-4B37-A6C7-C2DDD07E5F8EQ44962896-D9E165EA-7151-4BC5-8323-CD286CBE7CDFQ50081265-E499E0A0-D03A-44B4-B2A5-29222B64EB53Q54719345-5F977989-0301-4C95-9035-18BB58598804Q58700244-CB2A7444-48AA-4D50-BF35-9901A69224CA
P2860
Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Tumor cyclooxygenase-2 levels ...... uman hepatocellular carcinoma.
@ast
Tumor cyclooxygenase-2 levels ...... uman hepatocellular carcinoma.
@en
type
label
Tumor cyclooxygenase-2 levels ...... uman hepatocellular carcinoma.
@ast
Tumor cyclooxygenase-2 levels ...... uman hepatocellular carcinoma.
@en
prefLabel
Tumor cyclooxygenase-2 levels ...... uman hepatocellular carcinoma.
@ast
Tumor cyclooxygenase-2 levels ...... uman hepatocellular carcinoma.
@en
P2093
P2860
P356
P1476
Tumor cyclooxygenase-2 levels ...... uman hepatocellular carcinoma.
@en
P2093
Cecilia-P Lau
Ronnie-T Poon
Sheung-Tat Fan
Terence-C Tang
P2860
P304
P356
10.3748/WJG.V11.I13.1896
P407
P577
2005-04-01T00:00:00Z